STOCK OPTIONS AND WARRANTS (Details Narrative) - USD ($) |
1 Months Ended | 3 Months Ended | 9 Months Ended | 12 Months Ended | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
Jun. 13, 2018 |
May 15, 2018 |
May 25, 2017 |
Jun. 17, 2016 |
Sep. 30, 2018 |
Sep. 30, 2017 |
Sep. 30, 2018 |
Sep. 30, 2017 |
Dec. 31, 2017 |
Dec. 31, 2016 |
|
| Stock compensation expense | $ 950,814 | $ 83,853 | $ 1,398,614 | $ 240,924 | ||||||
| Stock compensation expense unamortized | $ 2,535,505 | |||||||||
| Weighted average remaining life | 8 months | |||||||||
| Warrant/rights exercisable price | $ 100.00 | $ 100.00 | ||||||||
| Warrant to purchase share | 57,500 | 57,500 | ||||||||
| Warrant term | 3 years | |||||||||
| Options granted | 315,000 | 350 | 330,000 | |||||||
| Option term | 5 years 6 months | |||||||||
| 2018 Equity Incentive Plan [Member] | ||||||||||
| Issuance of common stock, description | The Plan provides for the issuance of up to 450,000 shares of the Companys common stock, par value $0.001 per share | |||||||||
| Officers and Directors [Member] | ||||||||||
| Purchase of common stock by award option | 315,000 | |||||||||
| Stock option, vesting term, description | These options vest monthly over 12 months and have a term of 10 years. | |||||||||
| Option, exercise price | $ 14.00 | |||||||||
| Fair value of options | $ 3,803,258 | |||||||||
| Stock Options [Member] | ||||||||||
| Intrinsic value of the vested stock options price | $ 10.00 | $ 10.00 | $ 16.59 | |||||||
| Consultant [Member] | Stock Options [Member] | ||||||||||
| Fair value of options | $ 5,318 | |||||||||
| Warrant/rights exercisable price | $ 1.60 | |||||||||
| Options granted | 350 | |||||||||
| Option term | 5 years | |||||||||
| Vesting, description | Immediately | |||||||||
| Officer [Member] | ||||||||||
| Stock compensation expense | $ 319,460 | $ 183,249 | ||||||||
| Stock compensation expense unamortized | $ 130,892 | |||||||||
| Weighted average remaining life | 6 months | |||||||||
| Option, exercise price | $ 2.01 | |||||||||
| Fair value of options | $ 628,283 | |||||||||
| Options granted | 330,000 | |||||||||
| Option term | 10 years | |||||||||
| Extended term description | Company extended the term of previously granted options in aggregate of 135,000 initially expiring from November 2019 to July 2020 by five years to November 2024 to July 2025. | |||||||||
| Vesting, description | Monthly over 24 months | |||||||||
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Exercise price of the option. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of warrants or rights outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Description of award terms as to how many shares or portion of an award are no longer contingent on satisfaction of either a service condition, market condition or a performance condition, thereby giving the employee the legal right to convert the award to shares, to sell the shares, and be entitled to the cash proceeds of such sale. For example, vesting may be expressed as being 25 percent of the shares under option on each anniversary of the grant date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The maximum number of shares (or other type of equity) originally approved (usually by shareholders and board of directors), net of any subsequent amendments and adjustments, for awards under the equity-based compensation plan. As stock or unit options and equity instruments other than options are awarded to participants, the shares or units remain authorized and become reserved for issuance under outstanding awards (not necessarily vested). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of share options (or share units) granted during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Description of significant modifications (such as a change in expiration dating, vesting rights, or exercise prices) to an equity-based compensation plan, including the terms of the modifications. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Expected term of share-based compensation awards, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|